CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL BONE LOSS
- 23 April 1988
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 331 (8591), 900-902
- https://doi.org/10.1016/s0140-6736(88)91712-6
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Modified Method of Spinal Computed Tomography for Trabecular Bone Mineral MeasurementsJournal of Computer Assisted Tomography, 1986
- Measurement of the fasting urinary hydroxyproline: creatinine ratio in normal adults and its variation with age and sex.Journal of Clinical Pathology, 1982
- BONE FORMATION AND RESORPTION AS THE DETERMINANTS OF TRABECULAR BONE VOLUME IN POSTMENOPAUSAL OSTEOPOROSISThe Lancet, 1981
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981
- THE EFFECT OF OESTROGENS ON HUMAN CALCITONIN SECRETION AFTER CALCIUM INFUSION IN ELDERLY FEMALE SUBJECTSClinical Endocrinology, 1980
- Activities of bone and liver alkaline phosphatases in serum in health and diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Human CalcitoninNature, 1968
- FURTHER EVIDENCE FOR CALCITONIN A RAPID-ACTING HORMONE WHICH LOWERS PLASMA-CALCIUMThe Lancet, 1963
- Calcitonin—a Hormone from the Parathyroid which Lowers the Calcium-level of the BloodNature, 1962